{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:27Z","timestamp":1791488907022,"version":"4.3.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Although guidelines for the management of atrial fibrillation (AF) are regularly published, many controversial issues remain, limiting their implementation. We aim to describe current clinical practice among European Heart Rhythm Association (EHRA) community according to last guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A 30 multiple-choice questionnaire covering the most controversial topics related to AF management was distributed through the EHRA Research Network, National Societies, and social media between January and February 2023. One hundred and eighty-one physicians responded the survey, 61% from university hospitals. Atrial fibrillation screening in high-risk patients is regularly performed by 57%. Only 42% has access to at least one programme aiming at diagnosing\/managing comorbidities and lifestyle modifications, with marked heterogeneity between countries. Direct oral anticoagulants are the preferred antithrombotic (97%). Rhythm control is the preferred strategy in most AF phenotypes: symptomatic vs. asymptomatic paroxysmal AF (97% vs. 77%), low vs. high risk for recurrence persistent AF (90% vs. 72%), and permanent AF (20%). I-C drugs and amiodarone are preferred while dronedarone and sotalol barely used. Ablation is the first-line therapy for symptomatic paroxysmal AF (69%) and persistent AF with markers of atrial disease (57%) and is performed independently of symptoms by 15%. In persistent AF, 68% performs only pulmonary vein isolation and 32% also additional lesions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>There is marked heterogeneity in AF management and limited accordance to last guidelines in the EHRA community. Most of the discrepancies are related to the main controversial issues, such as those related to AF screening, management of comorbidities, pharmacological treatment, and ablation strategy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euae012","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T19:45:17Z","timestamp":1705434317000},"source":"Crossref","is-referenced-by-count":35,"title":["Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey\u2014how are we dealing with controversial approaches?"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-9177","authenticated-orcid":false,"given":"Jose M","family":"Guerra","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IR SANT PAU, Universitat Aut\u00f2noma de Barcelona, CIBERCV , Sant Antoni M. Claret 167, 08025 Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-4077","authenticated-orcid":false,"given":"Zoraida","family":"Moreno Weidmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IR SANT PAU, Universitat Aut\u00f2noma de Barcelona, CIBERCV , Sant Antoni M. Claret 167, 08025 Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-1183","authenticated-orcid":false,"given":"Laura","family":"Perrotta","sequence":"additional","affiliation":[{"name":"Arrhythmia Unit, Careggi University Hospital , Florence , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1807-4860","authenticated-orcid":false,"given":"Arian","family":"Sultan","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center, University of Cologne , K\u00f6ln , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6864-3999","authenticated-orcid":false,"given":"Ante","family":"Anic","sequence":"additional","affiliation":[{"name":"Department for Cardiovascular Diseases, University Hospital Centre, Split , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6818-6396","authenticated-orcid":false,"given":"Andreas","family":"Metzner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Hospital Hamburg-Eppendorf , Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-9883","authenticated-orcid":false,"given":"Rui","family":"Providencia","sequence":"additional","affiliation":[{"name":"Electrophysiology Department, Barts Heart Centre, St. Bartholomew\u2019s Hospital , London , UK"},{"name":"Institute of Health Informatics Research, University College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Rhythm Management , Clinique Pasteur, Toulouse , France"},{"name":"Brussels University VUB , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-6015","authenticated-orcid":false,"given":"Julian","family":"Chun","sequence":"additional","affiliation":[{"name":"Cardioangiologisches Centrum Bethanien (CCB), Medizinische Klinik III, Agaplesion Markus Krankenhaus , Frankfurt am Main , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"2024021600583842200_euae012-B1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024021600583842200_euae012-B2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/europace\/euz055","article-title":"EHRA White Paper: knowledge gaps in arrhythmia management\u2014status 2019","volume":"21","author":"Goette","year":"2019","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/europace\/euy039","article-title":"Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment","volume":"20","author":"Heidbuchel","year":"2018","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21290","article-title":"Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis","volume":"21","author":"Welton","year":"2017","journal-title":"Health Technol Assess"},{"key":"2024021600583842200_euae012-B6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/europace\/euz060","article-title":"Wrist band photoplethysmography in detection of individual pulses in atrial fibrillation and algorithm-based detection of atrial fibrillation","volume":"21","author":"Valiaho","year":"2019","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B8","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"2024021600583842200_euae012-B9","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.jacc.2019.04.052","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and liver disease","volume":"73","author":"Lee","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024021600583842200_euae012-B10","doi-asserted-by":"crossref","first-page":"h5876","DOI":"10.1136\/bmj.h5876","article-title":"Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study","volume":"351","author":"Staerk","year":"2015","journal-title":"BMJ"},{"key":"2024021600583842200_euae012-B11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ahj.2017.10.015","article-title":"Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time\u2014a RE-LY trial analysis","volume":"198","author":"Hijazi","year":"2018","journal-title":"Am Heart J"},{"key":"2024021600583842200_euae012-B12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/europace\/euaa423","article-title":"Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey","volume":"23","author":"Ivany","year":"2021","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sjalander","year":"2014","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B14","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jacc.2018.07.088","article-title":"Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery","volume":"72","author":"Butt","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024021600583842200_euae012-B15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","article-title":"Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.hrthm.2017.04.026","article-title":"Predicting determinants of atrial fibrillation or flutter for therapy elucidation in patients at risk for thromboembolic events (PREDATE AF) study","volume":"14","author":"Nasir","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024021600583842200_euae012-B17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2024021600583842200_euae012-B18","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.118.038988","article-title":"Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation","volume":"139","author":"Perino","year":"2019","journal-title":"Circulation"},{"key":"2024021600583842200_euae012-B19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/europace\/euac236","article-title":"Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey","volume":"25","author":"Iliodromitis","year":"2023","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2024021600583842200_euae012-B21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/europace\/euad185","article-title":"EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry","volume":"25","author":"Schmidt","year":"2023","journal-title":"Europace"},{"key":"2024021600583842200_euae012-B23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/pace.13015","article-title":"Left atrial substrate modification targeting low-voltage areas for catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"40","author":"Blandino","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024021600583842200_euae012-B24","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"2024021600583842200_euae012-B25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2010.07.046","article-title":"A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation","volume":"57","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024021600583842200_euae012-B26","first-page":"101175","article-title":"The scale of scientific evidence behind the current ESC clinical guidelines","volume":"45","author":"Tantawy","year":"2023","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euae012\/56151093\/euae012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/2\/euae012\/56671494\/euae012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/2\/euae012\/56671494\/euae012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:58:59Z","timestamp":1708045139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae012\/7560439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae012","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,1,16]]},"article-number":"euae012"}}